Vascular dysfunctions in the isolated aorta of double-transgenic hypertensive mice developing aortic aneurysm

Pflugers Archiv European Journal of Physiology

Volumn 467, Issue 9, 2015, Pages 1945-1963

  Waeckel, Ludovic ^a,b   Badier Commander, Cécile ^a   Damery, Thibaut ^a   Köhler, Ralf ^c,d   Sansilvestri Morel, Patricia ^a   Simonet, Serge ^a   Vayssettes Courchay, Christine ^a,b,c,d,e   Wulff, Heike ^e   Félétou, Michel ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aneurysms; Endothelium dependent and independent vasodilatation; Guanylyl cyclise; Hypertension; Oxidative stress

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; ANGIOTENSINOGEN; BRIMONIDINE; CATALASE; N(G) NITROARGININE METHYL ESTER; NORADRENALIN; POTASSIUM CHLORIDE; PROSTAGLANDIN SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; RENIN; SCAVENGER; SUPEROXIDE DISMUTASE; THROMBOXANE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ANEURYSM; ARTICLE; CONTROLLED STUDY; ELEVATED BLOOD PRESSURE; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HYPERTENSION; ISOLATED ORGAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; ANIMAL; C57BL MOUSE; COMPLICATION; DISEASE MODEL; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ORGAN CULTURE TECHNIQUE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; AORTA; AORTIC ANEURYSM; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORGAN CULTURE TECHNIQUES; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; VASODILATION;

EID: 84943453770     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-014-1644-6     Document Type: Article

References (85)

1. Badejo AM Jr, Nossaman VE, Pankey EA, Bhartiya M, Kannadka CB, Murthy SN, Nossaman BD, Kadowitz PJ (2010) Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase stimulator, BAY 41-8543, are modulated by nitric oxide. Am J Physiol Heart Circ Physiol 299:H1153–H1159
2. Blomkalns AL, Gavrila D, Thomas M, Neltner BS, Blanco VM, Benjamin SB, McCormick ML, Stoll LL, Denning GM, Collins SP, Qin Z, Daugherty A, Cassis LA, Thompson RW, Weiss RM, Lindower PD, Pinney SM, Chatterjee T, Weintraub NL (2013) CD14 directs adventitial macrophage precursor recruitment: role in early abdominal aortic aneurysm formation. J Am Heart Assoc 2(2): e000065
3. Brandes RP, Schmitz-Winnenthal FH, Félétou M, Gödecke A, Huang PL, Vanhoutte PM, Fleming I, Busse R (2000) An endotheliumderived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci U S A 97:9747–9752
4. Capettini LS, Cortes SF, Gomes MA, Silva GA, Pesquero JL, Lopes MJ, Teixeira MM, Lemos VS (2008) Neuronal nitric oxide synthasederived hydrogen peroxide is a major endothelium-dependent relaxing factor. Am J Physiol Heart Circ Physiol 295:H2503–H2511
5. Capettini LS, Cortes SF, Silva JF, Alvarez-Leite JI, Lemos VS (2011) Decreased production of neuronal NOS-derived hydrogen peroxide contributes to endothelial dysfunction in atherosclerosis. Br J Pharmacol 164:1738–1748
6. Carsten CG 3rd, Calton WC, Johanning JM, Armstrong PJ, Franklin DP, Carey DJ, Elmore JR (2001) Elastase is not sufficient to induce experimental abdominal aortic aneurysms. J Vasc Surg 33:1255–1262
7. Cassis LA, Gupte M, Thayer S, Zhang X, Charnigo R, Howatt DA, Rateri DL, Daugherty A (2009) ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Am J Physiol Heart Circ Physiol 296: H1660–H1665
8. Chung AW, Au Yeung K, Cortes SF, Sandor GG, Judge DP, Dietz HC, van Breemen C (2007) Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome. Br J Pharmacol 150:1075–1083
9. Chung AW, Yang HH, Radomski MW, van Breemen C (2008) Longterm doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ Res 102:e73–e85
10. Chung AW, Yang HH, van Breemen C (2007) Imbalanced synthesis of cyclooxygenase-derived thromboxane A2 and prostacyclin compromises vasomotor function of the thoracic aorta in Marfan syndrome. Br J Pharmacol 152:305–312
11. Cosentino F, Barker JE, Brand MP, Heales SJ, Werner ER, Tippins JR, West N, Channon KM, Volpe M, Lüscher TF (2001) Reactive oxygen species mediate endothelium-dependent relaxations in tetrahydrobiopterin-deficient mice. Arterioscler Thromb Vasc Biol 21:496–502
12. Daugherty A, Cassis LA (2004) Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 24:429–434
13. Daugherty A, Manning MW, Cassis LA (2001) Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Br J Pharmacol 134:865–870
14. Didion SP, Ryan MJ, Baumbach GL, Sigmund CD, Faraci FM (2002) Superoxide contributes to vascular dysfunction in mice that express human renin and angiotensinogen. Am J Physiol Heart Circ Physiol 283:H1569–H1576
15. Didion SP, Sigmund CD, Faraci FM (2000) Impaired endothelial function in transgenic mice expressing both human renin and human angiotensinogen. Stroke 31:760–764
16. Dikalov SI, Nazarewicz RR, Bikineyeva A, Hilenski L, Lassègue B, Griendling KK, Harrison DG, Dikalova AE (2014) Nox2-induced production of mitochondrial superoxide in angiotensin II-mediated endothelial oxidative stress and hypertension. Antioxid Redox Signal 20:281–294
17. Douglas G, Bendall JK, Crabtree MJ, Tatham AL, Carter EE, Hale AB, Channon KM (2012) Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE−/− mice. Cardiovasc Res 94:20–29
18. Durik M, Kavousi M, van der Pluijm I, Isaacs A, Cheng C, Verdonk K, Loot AE, Oeseburg H, Bhaggoe UM, Leijten F, van Veghel R, de Vries R, Rudez G, Brandt R, Ridwan YR, van Deel ED, de Boer M, Tempel D, Fleming I, Mitchell GF, Verwoert GC, Tarasov KV, Uitterlinden AG, Hofman A, Duckers HJ, van Duijn CM, Oostra BA, Witteman JC, Duncker DJ, Danser AH, Hoeijmakers JH, Roks AJ (2012) Nucleotide excision DNA repair is associated with agerelated vascular dysfunction. Circulation 126:468–478
19. Ellis A, Pannirselvam M, Anderson TJ, Triggle CR (2003) Catalase has negligible inhibitory effects on endothelium-dependent relaxations in mouse isolated aorta and small mesenteric artery. Br J Pharmacol 140:1193–1200
20. Evgenov OV, Pacher P, Schmidt PM, Haskó G, Schmidt HH, Stasch JP (2006) NO-independent stimulators and activators of soluble guanylyl cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 5:755–768
21. Fan LM, Douglas G, Bendall JK, McNeill E, Crabtree MJ, Hale AB, Mai A, Li JM, McAteer MA, Schneider JE, Choudhury RP, Channon KM (2014) Endothelial cell-specific reactive oxygen species production increases susceptibility to aortic dissection. Circulation 129: 2661–2672
22. Félétou M, Teisseire B (1990) Converting enzyme inhibition in isolated porcine resistance artery potentiates bradykinin relaxation. Eur J Pharmacol 190:159–166
23. Félétou M, Vanhoutte PM (2006) Endothelial dysfunction: a multifaceted disorder. Am J Physiol Heart Circ Physiol 291:H985–H1002
24. Félétou M, Vanhoutte PM (2006) EDHF, the complete story. Taylor & Francis CRC Press, Boca Raton
25. Félétou M, Vanhoutte PM, Verbeuren TJ (2010) The thromboxane/endoperoxide receptor (TP): the common villain. J Cardiovasc Pharmacol 55:317–332
26. Francois H, Makhanova N, Ruiz P, Ellison J, Mao L, Rockman HA, Coffman TM (2008) A role for the thromboxane receptor in LNAME hypertension.AmJ Physiol Renal Physiol 295:F1096–F1102
27. Fukamizu A, Sugimura K, Takimoto E, Sugiyama F, Seo MS, Takahashi S, Hatae T, Kajiwara N, Yagami K, Murakami K (1993) Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem 268:11617–11621
28. Gao L, Siu KL, Chalupsky K, Nguyen A, Chen P, Weintraub NL, Galis Z, Cai H (2012) Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation: treatment with folic acid. Hypertension 59:158–166
29. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B (1995) Potent and selective inhibition of nitric oxidesensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3- a]quinoxalin-1-one. Mol Pharmacol 48:184–188
30. Gavrila D, Li WG, McCormick ML, Thomas M, Daugherty A, Cassis LA, Miller FJ Jr, Oberley LW, Dellsperger KC, Weintraub NL (2005) Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 25:1671–1677
31. Guzik B, Sagan A, Ludew D, Mrowiecki W, Chwała M, Bujak- Gizycka B, Filip G, Grudzien G, Kapelak B, Zmudka K, Mrowiecki T, Sadowski J, Korbut R, Guzik TJ (2013) Mechanisms of oxidative stress in human aortic aneurysms—association with clinical risk factors for atherosclerosis and disease severity. Int J Cardiol 168:2389–2396
32. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model ofMarfan syndrome. Science 312: 117–121
33. Hasenau AL, Nielsen G, Morisseau C, Hammock BD, Wulff H, Köhler R (2011) Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediateconductance Ca2+-activated K+-channels. Acta Physiol (Oxf) 203: 117–126
34. Hashimoto T, Ichiki T, Watanabe A, Hurt-Camejo E, Michaëlsson E, Ikeda J, Inoue E, Matsuura H, Tokunou T, Kitamoto S, Sunagawa K (2014) Stimulation of α7 nicotinic acetylcholine receptor by ARR17779 suppresses atherosclerosis and aortic aneurysm formation in apolipoprotein E-deficient mice. Vascul Pharmacol 61:49–55
35. Hofmann Bowman M, Wilk J, Heydemann A, Kim G, Rehman J, Lodato JA, Raman J, McNally EM (2010) S100A12 mediates aortic wall remodeling and aortic aneurysm. Circ Res 106:145–154
36. Huang J, Yamashiro Y, Papke CL, Ikeda Y, Lin Y, Patel M, Inagami T, Le VP, Wagenseil JE, Yanagisawa H (2003) Angiotensinconverting enzyme-induced activation of local angiotensin signaling is required for ascending aortic aneurysms in fibulin-4-deficient mice. Sci Transl Med 5:183ra58
37. Iida S, Baumbach GL, Lavoie JL, Faraci FM, Sigmund CD, Heistad DD (2005) Spontaneous stroke in a genetic model of hypertension in mice. Stroke 36:1253–1258
38. Inaba T, Gotoda T, Harada K, Shimada M, Ohsuga J, Ishibashi S, Yazaki Y, Yamada N (1995) Induction of sustained expression of proto-oncogene c-fms by platelet-derived growth factor, epidermal growth factor, and basic fibroblast growth factor, and its suppression by interferon-gamma and macrophage colony-stimulating factor in human aortic medial smooth muscle cells. J Clin Invest 95:1133–1139
39. Jackson WF, Busse R (1991) Elevated guanosine 3′:5′-cyclic monophosphate mediates the depression of nitrovasodilator reactivity in endothelium-intact blood vessels. Naunyn Schmiedeberg’s Arch Pharmacol 344:345–350
40. Kent KC, Zwolak RM, Egorova NN, Riles TS, Manganaro A, Moskowitz AJ, Gelijns AC, Greco G (2010) Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg 52:539–548
41. Kuhlencordt PJ, Gyurko R, Han F, Scherrer-Crosbie M, Aretz TH, Hajjar R, Picard MH, Huang PL (2001) Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 104:448–454
42. Majesky MW, Dong XR, Hoglund VJ (2011) Parsing aortic aneurysms: more surprises. Circ Res 108:528–530
43. Manning MW, Cassi LA, Huang J, Szilvassy SJ, Daugherty A (2002) Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease. Vasc Med 7:45–54
44. Martin F, Baskaran P, Ma X, Dunten PW, Schaefer M, Stasch JP, Beuve A, van den Akker F (2010) Structure of cinaciguat (BAY 58- 2667) bound to nostoc H-NOX domain reveals insights into hememimetic activation of the soluble guanylyl cyclase. J Biol Chem 1285:22651–22657
45. McCormick ML, Gavrila D, Weintraub NL (2007) Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 27:461–469
46. Merrill DC, Thompson MW, Carney CL, Granwehr BP, Schlager G, Robillard JE, Sigmund CD (1996) Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest 97:1047–1055
47. Nishijo N, Sugiyama F, Kimoto K, Taniguchi K, Murakami K, Suzuki S, Fukamizu A, Yagami K (1998) Salt-sensitive aortic aneurysm and rupture in hypertensive transgenic mice that overproduce angiotensin II. Lab Invest 78:1059–1066
48. Nishijo N, Takamine S, Sugiyama F, Kimoto K, Taniguchi K, Horiguchi H, Ogata T, Murakami K, Fukamizu A, Yagami K (1999) Vascular remodeling in hypertensive transgenic mice. Exp Anim 48:203–208
49. Pankey EA, Bhartiya M, Badejo AM Jr, Haider U, Stasch JP, Murthy SN, Nossaman BD, Kadowitz PJ (2011) Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60-2770, are not dependent on endogenous nitric oxide or reduced heme. Am J Physiol Heart Circ Physiol 300:H792–H802
50. Priviero FB, Zemse SM, Teixeira CE, Webb RC (2009) Oxidative stress impairs vasorelaxation induced by the soluble guanylyl cyclase activator BAY 41-2272 in spontaneously hypertensive rats. Am J Hypertens 22:493–499
51. Rabelo LA, Cortes SF, Alvarez-Leite JI, Lemos VS (2003) Endothelium dysfunction in LDL receptor knockout mice: a role for H2O2. Br J Pharmacol 138:1215–1220
52. Radtke J, Schmidt K, Wulff H, Köhler R, deWit C (2013) Activation of KCa3.1 by SKA-31 induces arteriolar dilatation and lowers blood pressure in normo- and hypertensive connexin40-deficient mice. Br J Pharmacol 170:293–303
53. Ray R, Murdoch CE, Wang M, Santos CX, Zhang M, Alom-Ruiz S, Anilkumar N, Ouattara A, Cave AC, Walker SJ, Grieve DJ, Charles RL, Eaton P, Brewer AC, Shah AM (2011) Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler Thromb Vasc Biol 31:1368–1376
54. Rochelle LG, Morana SJ, Kruszyna H, Russell MA, Wilcox DE, Smith RP (1995) Interactions between hydroxocobalamin and nitric oxide (NO): evidence for a redox reaction between NO and reduced cobalamin and reversible NO binding to oxidized cobalamin. J Pharmacol Exp Ther 275:48–52
55. Roger S, Badier-Commander C, Paysant J, Cordi A, Verbeuren TJ, Félétou M (2010) The anti-aggregating effect of BAY 41-2272, a stimulator of soluble guanylyl cyclase, requires the presence of nitric oxide. Br J Pharmacol 161:1044–1058
56. Roger S, Paysant J, Badier-Commander C, Cordi A, Verbeuren TJ, Félétou M (2010) Anti-aggregating effect of BAY 58-2667, an activator of soluble guanylyl cyclase. Vascul Pharmacol 53:281–287
57. Roy B, Halvey EJ, Garthwaite J (2008) An enzyme-linked receptor mechanism for nitric oxide-activated guanylyl cyclase. J Biol Chem 283:18841–18851
58. Roy B, Mo E, Vernon J, Garthwaite J (2008) Probing the presence of the ligand-binding haem in cellular nitric oxide receptors. Br J Pharmacol 153:1495–1504
59. Ryan MJ, Didion SP, Davis DR, Faraci FM, Sigmund CD (2002) Endothelial dysfunction and blood pressure variability in selected inbred mouse strains. Arterioscler Thromb Vasc Biol 22:42–48
60. Safar ME, London GM, Asmar R, Frohlich ED (1998) Recent advances on large arteries in hypertension. Hypertension 32:156–161
61. Sankaranarayanan A, Raman G, Busch C, Schultz T, Zimin PI, Hoyer J, Köhler R, Wulff H (2009) Naphtho[1,2-d]thiazol-2-ylamine (SKA- 31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure. Mol Pharmacol 75:281–295
62. Schiffrin EL (2004) Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 17:1192–1200
63. Schmidt HH, Schmidt PM, Stasch JP (2009) NO- and haemindependent soluble guanylate cyclase activators. Handb Exp Pharmacol 191:309–339
64. Schmidt P, Schramm M, Schröder H, Stasch JP (2003) Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase. Eur J Pharmacol 468:167–174
65. Schröder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J, Kruse C, Luedike P, Michaelis UR, Weissmann N, Dimmeler S, Shah AM, Brandes RP (2012) Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res 110:1217–1225
66. Sethi S, Iida S, Sigmund CD, Heistad DD (2006) Renal thrombotic microangiopathy in a genetic model of hypertension in mice. Exp Biol Med (Maywood) 231:196–203
67. Seto SW, Krishna SM, Yu H, Liu D, Khosla S, Golledge J (2013) Impaired acetylcholine-induced endothelium-dependent aortic relaxation by caveolin-1 in angiotensin II-infused apolipoprotein-E (ApoE−/−) knockout mice. PLoS One 8(3):e58481
68. Shafaroudi MM, McBride M, Deighan C, Wokoma A, Macmillan J, Daly CJ, McGrath JC (2005) Two “knockout” mouse models demonstrate that aortic vasodilatation is mediated via alpha2aadrenoceptors located on the endothelium. J Pharmacol Exp Ther 314:804–810
69. Shimokawa H (2010) Hydrogen peroxide as an endothelium-derived hyperpolarizing factor. Pflugers Arch 459:915–922
70. Simonet S, Descombes JJ, Vallez MO, Dubuffet T, Lavielle G, Verbeuren TJ (1997) S 18886, a new thromboxane (TP)-receptor antagonist is the active isomer of S 18204 in all species, except in the guinea-pig. Adv Exp Med Biol 433: 173–176
71. Stasch JP, Becker EM, Alonso-Alija C, Apeler H, Dembowsky K, Feurer A, Gerzer R, Minuth T, Perzborn E, Pleiss U, Schröder H, Schroeder W, Stahl E, Steinke W, Straub A, Schramm M(2001) NOindependent regulatory site on soluble guanylate cyclase. Nature 410: 212–215
72. Stasch JP, Hobbs AJ (2009) NO-independent, haem-dependent soluble guanylate cyclase stimulators. Handb Exp Pharmacol 191:277–308
73. Stasch JP, Schmidt P, Alonso-Alija C, Apeler H, Dembowsky K, Haerter M, Heil M, Minuth T, Perzborn E, Pleiss U, Schramm M, Schroeder W, Schröder H, Stahl E, Steinke W, Wunder F (2002) NOand haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. Br J Pharmacol 136:773–783
74. Stasch JP, Schmidt PM, Nedvetsky PI, Nedvetskaya TY, Arun Kumar HS, Meurer S, Deile M, Taye A, Knorr A, Lapp H, Müller H, Turgay Y, Rothkegel C, Tersteegen A, Kemp-Harper B, Müller-Esterl W, Schmidt HH (2006) Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. J Clin Invest 116:2552–2561
75. Sutliff RL, Hilenski LL, Amanso AM, Parastatidis I, Dikalova AE, Hansen L, Datla SR, Long JS, El-Ali AM, Joseph G, Gleason RL Jr, Taylor WR, Hart CM, Griendling KK, Lassègue B (2013) Polymerase delta interacting protein 2 sustains vascular structure and function. Arterioscler Thromb Vasc Biol 33:2154–2161
76. Syyong HT, Chung AW, Yang HH, van Breemen C (2009) Dysfunction of endothelial and smooth muscle cells in small arteries of a mouse model of Marfan syndrome. Br J Pharmacol 158:1597–1608
77. Tang EH, Ku DD, Tipoe GL, Feletou M, Man RY, Vanhoutte PM (2005) Endothelium-dependent contractions occur in the aorta of wild-type and COX2 −/− knockout but not COX1 −/− knockout mice. J Cardiovasc Pharmacol 46:761–765
78. Thomas M, Gavrila D, McCormick ML, Miller FJ Jr, Daugherty A, Cassis LA, Dellsperger KC, Weintraub NL (2006) Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice. Circulation 114: 404–413
79. Varo N, Iraburu MJ, Varela M, López B, Etayo JC, Díez J (2000) Chronic AT(1) blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats. Hypertension 35:1197–1202
80. Verbeuren TJ, Jordaens FH, Zonnekeyn LL, Van Hove CE, Coene MC, Herman AG (1986) Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endotheliumindependent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circ Res 58:552–564
81. Waeckel L, Bertin F, Clavreul N, Damery T, Köhler R, Paysant J, Sansilvestri-Morel P, Simonet S, Vayssettes-Courchay C, Wulff H, Verbeuren TJ, Félétou M (2014) Preserved regulation of renal perfusion pressure by small and intermediate conductance KCa channels in hypertensive mice with or without renal failure. Pflugers Arch [Epub ahead of print]
82. Weinberg JB, Chen Y, Jiang N, Beasley BE, Salerno JC, Ghosh DK (2009) Inhibition of nitric oxide synthase by cobalamins and cobinamides. Free Radic Biol Med 46:1626–1632
83. Xie Y, Chen C, Hume DA (2001) Transcriptional regulation of c-fms gene expression. Cell Biochem Biophys 34:1–16
84. Yang HH, Kim JM, Chum E, van Breemen C, Chung AW(2009) Longterm effects of losartan on structure and function of the thoracic aorta in a mouse model of Marfan syndrome. Br J Pharmacol 158:1503–1512
85. Yang HH, van Breemen C, Chung AW (2010) Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress. Vascul Pharmacol 52:37–45